NDC 0078-0911

Xiidra

Lifitegrast

Xiidra is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Lifitegrast.

• Product ID: 0078-0911_1de81040-6b02-4632-afec-bde1e05391da
• NDC: 0078-0911
• Product Type: Human Prescription Drug
• Proprietary Name: Xiidra
• Generic Name: Lifitegrast
• Dosage Form: Solution/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 2016-07-11
• Marketing Category: NDA / NDA
• Application Number: NDA208073
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: LIFITEGRAST
• Active Ingredient Strength: 50 mg/mL
• Pharm Classes: Lymphocyte Function-Associated Antigen-1 Antagonist [EPC],Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0078-0911-12

12 POUCH in 1 CARTON (0078-0911-12) > 5 AMPULE in 1 POUCH (0078-0911-05) > .2 mL in 1 AMPULE

• Marketing Start Date: 2020-06-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Xiidra" or generic name "Lifitegrast"

NDC	Brand Name	Generic Name
0078-0911	Xiidra	Lifitegrast
54092-606	Xiidra	Lifitegrast